Being overweight or obese promotes microalbuminuria and increases the risk of chronic kidney disease. This study aimed to develop a mathematical model to estimate the risk of microalbuminuria in overweight Chinese men. Urine albumin/creatinine ratio and metabolic variables were assessed in 1179 subjects, randomly divided into estimation and validation groups that were comparable with respect to all variables. Regression analysis identified body mass index, systolic blood pressure, fasting plasma glucose and blood uric acid as significant variables; these were used to develop a mathematical model for estimating the risk of microalbuminuria. The model generated a receiver-operating characteristic curve indicative of strong predictive accuracy for microalbuminuria (area under the curve, 0.81). A probability cut-off point of 0.50 resulted in global predictive values for microalbuminuria of 86.4% and 84.1% in the validation group (n = 354) and in all subjects, respectively. This model provides a beneficial tool for identifying overweight Chinese men at risk of microalbuminuria; additional studies are required to examine the predictive ability of the model further.
CuiZHuxleyRWuY: Temporal trends in overweight and obesity of children and adolescents from nine Provinces in China from 1991–2006. Int J Pediatr Obes2010; 5: 365–374.
2.
PopkinBM: Will China's nutrition transition overwhelm its health care system and slow economic growth?Health Aff (Millwood)2008; 27: 1064–1076.
3.
RhéaumeCArsenaultBJBélangerS: Low cardiorespiratory fitness levels and elevated blood pressure: what is the contribution of visceral adiposity?Hypertension2009; 54: 91–97.
4.
YokoyamaHSoneHOishiM: Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant2009; 24: 1212–1219.
5.
HunleyTEMaLJKonV: Scope and mechanisms of obesity-related renal disease. Curr Opin Nephrol Hypertens2010; 19: 227–234.
6.
NugentRAFathimaSFFeiglAB: The burden of chronic kidney disease on developing nations: A 21st century challenge in global health. Nephron Clin Pract2011; 118: c269–c277.
7.
IkizlerTA: CKD classification: time to move beyond KDOQI. J Am Soc Nephrol2009; 20: 929–930.
8.
de JongPECurhanGC: Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol2006; 17: 2120–2126.
9.
American Diabetes Association: Standards of medical care in diabetes–2008. Diabetes Care2008; 31 (suppl 1): S12–S54.
10.
National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis2002; 39 (2 suppl 1): S1–S266.
11.
BoulwareLEJaarBGCarrME Tarver: Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA2003; 290: 3101–3114.
12.
LocatelliFPozzoniPDel VecchioL: Renal manifestations in the metabolic syndrome. J Am Soc Nephrol2006; 17 (4 suppl 2): S81–S85.
13.
ChenJGuDChenCS: Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant2007; 22: 1100–1106.
14.
RossiMCNicolucciAPellegriniF: Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant2008; 23: 1278–1284.
15.
WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet2004; 363: 157–163.
16.
BabazonoTTakahashiCIwamotoY: Definition of microalbuminuria in first-morning and random spot urine in diabetic patients. Diabetes Care2004; 27: 1838–1839.
17.
AlbertiKGZimmetPShawJ: The metabolic syndrome—a new worldwide definition. Lancet2005; 366: 1059–1062.
WuCCLiouHHSuPF: Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients. Nephrol Dial Transplant2011; 26: 3689–3695.
NinomiyaTKiyoharaY: Albuminuria and chronic kidney disease in association with the metabolic syndrome. J Cardiometab Syndr2007; 2: 104–107.
22.
ChenBYangDChenY: The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta2010; 411: 705–709.
23.
OrchardTJChangYFFerrellRE: Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int2002; 62: 963–970.
24.
TolonenNForsblomCThornL: Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia2009; 52: 2522–2530.
25.
MuntnerPCoreshJSmithJC: Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int2000; 58: 293–301.
26.
KimESKwonHSAhnCW: Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus. J Diabetes Complications2011; 25: 309–313.
27.
HosmerDWLemeshowS (eds): Applied Logistic Regression2nd edn.New York: John Wiley, 2000.
28.
van der TolAVan BiesenWVerbekeF: Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial. PLoS One2010; 5: e13328.
29.
OgunniyiMOCroftJBGreenlundKJ: Racial/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999–2006. Am J Hypertens2010; 23: 859–864.
